Novel immunomodulatory and antibiofilm innate defense regulator peptide

Angiotensin converting enzyme (ACE) inhibitor

Selective serotonin 5-HT2A receptor antagonist

Novel Type I Interferon Inducer

Novel Type I Interferon Inducer

Novel Type I Interferon Inducer; Intercalator of DNA; Inhibitor of the retrovirus replications including HIV

First Small-Molecule Inhibitor of RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy

Novel Inhibitor of RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy

Novel Inhibitor of RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy

Highly potent fluorescent iGlu receptor antagonist

Novel dual SMO-HDAC antagonist, retaining similar specificity for SAHA-targeted HDACs, disabling deviant Hedgehog signaling and preventing GLI binding to DNA

Natural Inhibitor of Clathrin-Mediated Endocytosis

Novel allosteric inhibitor of IκBα phosphorylation and NF-κB transcriptional activity through selective capture of the inactive conformation and hence blockade of IKKβ S177/S181 phosphorylation

Antineoplastic phospholipid, being effective against many tumor types, including ovary, non-small cell lung, kidney, and melanoma, exhibiting competitive inhibition of protein kinase C (PKC) activity

Dual D 2 /5-HT 2 antagonist as an antipsychotic agent

Novel orally effective direct renin inhibitor for treating diabetic nephropathy and hypertension

Novel anti-tuberculosis agent, targeting Mycobacterial tuberculosis (Mtb) aspartate semialdehyde dehydrogenase

Novel inhibitor of protein kinase B (PknB), inhibiting PknB auto-phosphorylation and the phosphorylation of GarA by PknB in a dose-dependent manner

BCL2 i-motif-interactive compound, stabilizing or facilitating the folding of the i-motif

BCL2 i-motif-interactive compound, destabilizing or unfolding the i-motif

Insect neurotoxin, blocking nicotinic acetylcholine receptors and preventing acetylcholine from transmitting impulses between nerves

Novel potent inhibitor of BV2 microglia activation, protecting PC12 cells and primary neurons against indirect toxicity mediated by exposure to conditioned medium (CM) from LPS-treated BV2 cells